Correspondence 0001193125-23-212303 from Trevi Therapeutics, Inc. (TRVI) (CIK 0001563880) (TRVI)
Trevi Therapeutics, Inc. (TRVI) (CIK 0001563880)
Date: Aug. 14, 2023 · CIK: 0001563880 · Accession: 0001193125-23-212303
AI Filing Summary & Sentiment
File numbers found in text: 333-273030
Letter
Acceleration Request
August 14, 2023
VIA EDGAR SUBMISSION
Securities and Exchange Commission
Division of Corporation Finance, Office of Life Sciences
100 F Street, NE
Washington, DC 20549
Attention: Dillon Hagius
Re: Trevi Therapeutics, Inc.
Registration Statement on Form S-3
File No. 333-273030
Request for Acceleration
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, Trevi Therapeutics, Inc. (the “Company”) hereby requests acceleration of the effective date of its Registration Statement on Form S-3 (File No. 333-273030), so that it may become effective at 4:00 p.m., Eastern Time, on August 15, 2023, or as soon as practicable thereafter.
Very truly yours,
TREVI THERAPEUTICS, INC.
Show Raw Text
CORRESP 1 filename1.htm Acceleration Request August 14, 2023 VIA EDGAR SUBMISSION Securities and Exchange Commission Division of Corporation Finance, Office of Life Sciences 100 F Street, NE Washington, DC 20549 Attention: Dillon Hagius Re: Trevi Therapeutics, Inc. Registration Statement on Form S-3 File No. 333-273030 Request for Acceleration Ladies and Gentlemen: Pursuant to Rule 461 under the Securities Act of 1933, as amended, Trevi Therapeutics, Inc. (the “Company”) hereby requests acceleration of the effective date of its Registration Statement on Form S-3 (File No. 333-273030), so that it may become effective at 4:00 p.m., Eastern Time, on August 15, 2023, or as soon as practicable thereafter. Very truly yours, TREVI THERAPEUTICS, INC. By: /s/ Jennifer L. Good Name: Jennifer L. Good Title: Chief Executive Officer